2016-2020 Global Nucleic Acid Testing/NAT Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, Competitive Strategies, Emerging Opportunities--Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing

March 2016 | 1398 pages | ID: 208CC1730AFEN
Venture Planning Group

Abstracts

This unique seven-country report,1,398-page report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the NAT market during this decade.

Highlights

Business and technological trends in seven major markets - Five- and ten-year test volume and sales forecasts - Market shares of leading competitors - Feature comparison of major analyzers - Profiles of market players and start-up firms developing innovative technologies and products - Specific product and business opportunities for instrument and consumable suppliers

Rationale

The NAT market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the NAT market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next ten years

Geographic Coverage

France - Germany - Italy - Japan - Spain - UK - USAWorldwide Market Overview

Laboratories performing DNA sequencing and NAT by country and market segment. Five-year test volume and sales projections by countryMarket Segmentation Analysis Sales and market shares of major suppliers of NAT reagent kits and components. Ten-year test volume and sales forecasts for major applications, including:- Infectious Diseases - Forensic Testing - Cancer

Paternity Testing/HLA Typing - Genetic Diseases - Others- Ten-year test volume and sales projections for over 30 NAT assays. A comprehensive analysis of the sequencing market, by country and laboratory segment, including:- Industrial - Academic - Government - Commercial- Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers, by country

Product/Technology Review

Comparison of leading NAT analyzers from Abbott, Beckman Coulter, BD, Bio-Rad, Gen-Probe, Roche, Tecan and other suppliers. Extensive review of NAT technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods, including:- PCR - bDNA - SDA - NASBA - TMA - SSSR, and others - LCR- Worldwide listings of companies, universities and research centers developing new NAT technologies and products.

Competitive Assessments

Extensive strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D. Comprehensive listings of companies developing and marketing NAT products, by test and application

Opportunities and Strategic Recommendations

Specific new product development opportunities with potentially significant market appeal during the next ten years. Design criteria for new products. Alternative market penetration strategies. Potential market entry barriers and risks. Business planning issues and concerns

MethodologyThis report is based on a combination of primary and secondary information sources, including interviews with laboratory directors and executives of leading diagnostic companies and start-up firms developing innovative technologies and products in the U.S., five major European countries and Japan.

In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as VPGMarketResearchs proprietary data base was conducted.

Contains 1,398 pages and 194 tables

Contents

1. INTRODUCTION

2. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

A. INSTRUMENTATION

B. Reagent Kits and Test Systems/panels
C. Computers, Software and Automation
D. Auxiliary Products

3. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

4. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies For Decentralized Testing Markets

5. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge And Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

6. WORLDWIDE MARKET AND TECHNOLOGY REVIEW

A. DNA Sequencing
  1. INTRODUCTION
  2. SEQUENCING METHODS
  3. AUTORADIOGRAPHY
  4. THE HUMAN GENOME PROJECT
  5. SEQUENCING AUTOMATION
  6. IMAGE SCANNERS
  7. FLUORESCENT DETECTION
  8. GENE PROFILING
  9. GENE EXPRESSION
  10. POLYMORPHISM SCREENING
  11. PROTEIN INTERACTION NETWORKS
B. DNA and RNA Probe Technologies
  1. BASIC PRINCIPLES
  2. PROBE PREPARATION
  3. THE DNA PROBE TEST
  4. TEST FORMATS
  5. LABELING TECHNIQUES
  6. AMPLIFICATION METHODS
C. Detection Technologies
  1. RADIOACTIVE METHODS
    a. Overview
    b. Major Isotopes
      P-32
      S-35
      H-3
      I-125
  2. NON-ISOTOPIC METHODS
    a. Enzymatic Labels
    b. Chemical Labeling
@ Indirect Chemical Labeling
@ Direct Chemical Labeling
    c. Fluorescence
    d. Chemiluminescence
    e. Electrical Conductivity
D. Molecular Diagnostic INSTRUMENTATION Review
  1. ABBOTT LCX
  2. BECKMAN COULTER/BIOMEK FK
  3. BD VIPER SYSTEM WITH XTR TECHNOLOGY
  4. BD INNOVA
  5. BECTON DICKINSON SDA
  6. BIOMERIEUX NUCLISENS EASYMAG
  7. BIOMERIEUX NUCLISENS EASYQ AND MINIMAG
  8. BIO-RAD GENESCOPE
  9. CEPHEID GENEXPERT
  10. CURETIS UNYVERO
  11. GENMARK DX ESENSOR XT-8
  12. HOLOGIC/GEN-PROBE PANTHER
  13. HOLOGIC/GEN-PROBE TIGRIS/DTS
  14. HTG MOLECULAR EDGE
  15. LIFE TECHNOLOGIES QUANTSTUDIO DX
  16. QIAGEN QIASYMPHONY RGQ
  17. ROCHE COBAS AMPLICOR
  18. ROCHE COBAS TAQMAN
  19. ROCHE COBAS TAQMAN
  20. ROCHE COBAS TAQMAN AMPLIPREP
  21. ROCHE LIGHCYCLER
  22. ROCHE COBAS 4800
  23. ROCHE COBAS S
  24. SIEMENS VERSANT
  25. TECAN LS SERIES
E. Biochips: Genosensors, Microarrays, and Labs-on-the-Chip
  Liquid Transportation and Mixing
  Separation
  Reaction
  Detection
F. Pharmacogenomics
G. Major Applications
  1. MICROBIOLOGY/INFECTIOUS DISEASES
    a. Overview
    b. Major Infectious Diseases
      AIDS: HIV/HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II
      Adenovirus
      Aeromonas
      Anthrax/Bacillus Anthracis
      Arboviruses
      Babesiosis
      Bacillary Epithelioid Angiomatosis (BEA) and Other Bartonella (Rochalimaea)
      Blastocystis Hominis
      Brucella
      Campylobacter
      Candida
      Chagas Disease
      Chancroid
      Chlamydia
      Clostridium Difficile
      Coronaviruses
      Coxsackieviruses
      Creutzfeldt-Jakob’s Disease
      Cryptosporidium Parvum
      Cyclospora Cayetanensis
      Cytomegalovirus
      Ebola Virus
      E. Coli
      EchoVirus
      Encephalitis
      Enteroviruses
      Epstein-Barr Virus
      Giardia Lamblia
      Gonorrhea
      Granuloma Inguinale
      Hantavirus
      Helicobacter Pylori
      Hepatitis: HAV NAT, HBV NAT, HBs Ag, HCV, HCV NAT, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, ALT/SGPT
      Herpes Simplex Virus
      Human Herpes Virus-6 (HHV-6)
      Influenza Viruses
      Legionella
      Lyme Disease
      Lymphogranuloma Venereum (LGV)
      Malaria
      Measles (Rubeola)
      Meningitis
      Microsporidium
      Mononucleosis
      Mumps
      Mycoplasma
      Papillomaviruses
      Parvovirus B19
      Pneumonia
      Polyomaviruses
      Pseudomonas Aeruginosa
      Rabies
      Respiratory Syncytial Virus (RSV)
      Rhinoviruses
      Rotavirus
      Rubella
      Salmonellosis
      Septicemia
      Shigellosis
      Staphylococcus Aureus
      Streptococci
      Syphilis
      Toxoplasmosis
      Trichomonas Vaginalis
      Tuberculosis
      Vibrio
      West Nile Virus
      Yersina
  2. CANCER TESTING
    a. Overview
    b. Major Cancer Types
      Prostate
      Lung
      Colon and Rectum
      Breast
      Skin
      Uterine
      Leukemia
      Oral
    c. Oncogenes
@ Abl/abl-bcr
      AIB1
      BCL-2
      BRCA1
      CD44
@ C-fos
@ C-myb
@ C-myc
      CYP17

@ Erb-B
      HPC1
O N-myc

O P40
      P51
      P53
      PIK3CA
      PTI-1
@ Ras
O Reg
@ Sis
@ Src
  3. GENETIC DISEASES
    a. Overview
    b. Nucleic Acid Amplification
    c. Chromosome Imaging
    d. Genomics Technologies
    e. Proteomics Technologies
    f. Current Pharmacogenomic Tests
    g. Future Pharmacogenomic Testing
    h. Major Diseases
      Achondroplasia
      Autosomal Dominant Polycystic Kidney Disease
      Cancer
      Cosmetogenomics
      Cystic Fibrosis
      Down's Syndrome
      Duchenne and Becker Muscular Dystrophy
      Factor V (Leiden)
      Factor IX Deficiency
      Fragile X Syndrome
      Heart Disease
      Hemochomatosis
      Hemophilia
      Huntington's Disease
      Maternal-Fetal Incompatibility
      Multiple Endocrine Neoplasia
      Phenylketonuria (PKU)
      Polycystic Kidney Disease (PKD)
      Prenatal Screening
      Retinitis Pigmentosa
      Retinoblastoma
      Sickle Cell Anemia
      Spinal Muscular Atrophy
      Vitamin B12 Metabolism
    i. Social Issues and Concerns
  4. FORENSIC TESTING
    a. Overview
    b. Multilocus and Single Locus Probes
      Multilocus Probes
      Single Locus Probes
      PCR and RFLP
    c. The FBI
    d. DNA Profile Data Banks
      U.S.A.
      U.K.
    e. Judicial Implementation
    f. Major Crime Categories
    g. Factors Contributing to the DNA Probe Market Expansion
      Technology Availability
      Use of Hair as Evidence
    h. Wildlife Forensics
  5. PATERNITY TESTING/HLA TYPING
  6. OTHER APPLICATIONS
    a. Disease Susceptibility Testing
    b. Cardiovascular Diseases
    c. Diabetes
    d. Alzheimer's Disease
    e. Periodontal Disease
    f. Plasma Purification
    g. Organ Transplantation
    h. Water Contamination
    i. Other
H. Competing/complementing
  1. MONOCLONAL ANTIBODIES/IMMUNOASSAYS
  2. RNA PROBES
  3. TWO-DIMENSIONAL ELECTROPHORESIS
  4. FLOW CYTOMETRY

7. WORLDWIDE MARKET OVERVIEW

  1. BUSINESS ENVIRONMENT
  2. MARKET STRUCTURE
  3. MARKET SIZE AND GROWTH

8. FRANCE MOLECULAR DIAGNOSTICS MARKET

A. EXECUTIVE SUMMARY
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares

9. GERMANY MOLECULAR DIAGNOSTICS MARKET

A. EXECUTIVE SUMMARY
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares

10. ITALY MOLECULAR DIAGNOSTICS MARKET

A. EXECUTIVE SUMMARY
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares

11. JAPAN MOLECULAR DIAGNOSTICS MARKET

A. EXECUTIVE SUMMARY
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares

12. SPAIN MOLECULAR DIAGNOSTICS MARKET

A. EXECUTIVE SUMMARY
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares

13. U.K. MOLECULAR DIAGNOSTICS MARKET

A. EXECUTIVE SUMMARY
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares

14. U.S.A. MOLECULAR DIAGNOSTICS MARKET

A. EXECUTIVE SUMMARY
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares

15. COMPETITIVE ASSESSMENTS

  Abbott
  Affymetrix
  Agilent Technologies
  Applied Gene Technologies
  Arca Biopharma
  Beckman Coulter/Danaher
  Becton Dickinson
  Biokit
  bioMerieux
  Bio-Rad
  Biotest
  Cepheid
  CellMark Forensics/LabCorp
  Decode Genetics
  Diadexus
  Eiken
  Elitech Group
  Enzo
  Exact Sciences
  Fujirebio
  Grifols
  Hologic/Gen-Probe
  Illumina
  Kreatech/Leica
  Li-Cor Biosciences
  Monogram Biosciences/LabCorp
  Myriad Genetics
  Ortho-Clinical Diagnostics
  Perkin Elmer/Caliper
  Proteome Sciences
  Qiagen
  Roche
  Scienion
  Sequenom
  Shimadzu
  Siemens
  Sierra Molecular
  Takara Bio
  Tecan Group
  Thermo Fisher

16. APPENDIX: MAJOR UNIVERSITIES AND RESEARCH CENTERS DEVELOPING MOLECULAR DIAGNOSTIC TECHNOLOGIES

List Of Tables

LIST OF TABLES

Major Companies Developing or Marketing AIDS Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Adenovirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Bartonella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Campylobacter Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Candida Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Chlamydia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Clostridium Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Coronavirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Cryptosporidium Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing CMV Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Echovirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Enterovirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing EBV Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Giardia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Gonorrhea Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Hantavirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Helicobacter Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Hepatitis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Herpes Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Influenza Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Legionella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Lyme Disease Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Measles Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Meningitis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mononucleosis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mumps Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mycoplasma Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Pneumonia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing RSV Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Rotavirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Rubella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Salmonella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Septicemia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Shigella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Streptococci Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Syphilis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Toxoplasmosis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Trichomonas Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Tuberculosis Molecular Diagnostic and Other Direct Identification Tests Oncogenes Potential Application in Cancer Diagnosis
Major Companies Developing or Marketing Cancer Molecular Diagnostic Tests
Major Companies Developing or Marketing Molecular Diagnostic Tests For Genetic Diseases
Worldwide, Laboratories Performing DNA Sequencing by Country
Worldwide, Molecular Diagnostics Market Potential Laboratory Universe by Country
Worldwide, Molecular Diagnostic Test Volume Forecast by Country
Worldwide, Molecular Diagnostics Market Forecast by Country
France Molecular Diagnostics Test Volume And Sales By Major Application
France Laboratories Performing DNA Sequencing By Market Segment
France Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
France Molecular Diagnostics Test Volume By Major Application
France Major Infectious Disease Test Volume by Assay
France Major Infectious Disease Test Volume by Method
France Molecular Diagnostics Market By Major Application
France Molecular Diagnostics Market Estimated Sales And Market Shares of Major Suppliers
France Major Infectious Disease Diagnostics Market by Assay
France AIDS Testing Market Estimated Sales by Major Supplier
France Adenovirus Testing Market Estimated Sales by Major Supplier
France Chlamydia Testing Market Estimated Sales by Major Supplier
France CMV Testing Market Estimated Sales by Major Supplier
France Gonorrhea Testing Market Estimated Sales by Major Supplier
France Hepatitis Testing Market Estimated Sales by Major Supplier
France Hepatitis C Testing Market Estimated Sales by Major Supplier
France HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
France Herpes Testing Market Estimated Sales by Major Supplier
France Influenza Testing Market Estimated Sales by Major Supplier
France Meningitis Testing Market Estimated Sales by Major Supplier
France Mycoplasma Testing Market Estimated Sales by Major Supplier
France RSV Testing Market Estimated Sales by Major Supplier
France Shigella Testing Market Estimated Sales by Major Supplier
Germany Molecular Diagnostics Test Volume And Sales By Major Application
Germany Laboratories Performing DNA Sequencing By Market Segment
Germany Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
Germany Molecular Diagnostics Test Volume By Major Application
Germany Major Infectious Disease Test Volume by Assay
Germany Major Infectious Disease Test Volume by Method
Germany Molecular Diagnostics Market By Major Application
Germany Molecular Diagnostics Market Estimated Sales And Market Shares of Major Suppliers
Germany Major Infectious Disease Diagnostics Market by Assay
Germany AIDS Testing Market Estimated Sales by Major Supplier
Germany CMV Testing Market Estimated Sales by Major Supplier
Germany EBV Testing Market Estimated Sales by Major Supplier
Germany Gonorrhea Testing Market Estimated Sales by Major Supplier
Germany Hepatitis Testing Market Estimated Sales by Major Supplier
Germany Hepatitis C Testing Market Estimated Sales by Major Supplier
Germany HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
Germany Herpes Testing Market Estimated Sales by Major Supplier
Germany Influenza Testing Market Estimated Sales by Major Supplier
Germany Meningitis Testing Market Estimated Sales by Major Supplier
Germany Mycoplasma Testing Market Estimated Sales by Major Supplier
Germany Pneumonia Testing Market Estimated Sales by Major Supplier
Germany RSV Testing Market Estimated Sales by Major Supplier
Germany Rotavirus Testing Market Estimated Sales by Major Supplier
Italy Molecular Diagnostics Test Volume And Sales By Major Application
Italy Laboratories Performing DNA Sequencing By Market Segment
Italy Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
Italy Molecular Diagnostics Test Volume By Major Application
Italy Major Infectious Disease Test Volume by Assay
Italy Major Infectious Disease Test Volume by Method
Italy Molecular Diagnostics Market By Major Application
Italy Molecular Diagnostics Market Estimated Sales And Market Shares of Major Suppliers
Italy Major Infectious Disease Diagnostics Market by Assay
Italy AIDS Testing Market Estimated Sales by Major Supplier
Italy CMV Testing Market Estimated Sales by Major Supplier
Italy Gonorrhea Testing Market Estimated Sales by Major Supplier
Italy Hepatitis Testing Market Estimated Sales by Major Supplier
Italy Hepatitis C Testing Market Estimated Sales by Major Supplier
Italy HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
Italy Herpes Testing Market Estimated Sales by Major Supplier
Italy Influenza Testing Market Estimated Sales by Major Supplier
Italy Meningitis Testing Market Estimated Sales by Major Supplier
Italy Mycoplasma Testing Market Estimated Sales by Major Supplier
Italy RSV Testing Market Estimated Sales by Major Supplier
Japan Molecular Diagnostics Test Volume And Sales By Major Application
Japan Laboratories Performing DNA Sequencing By Market Segment
Japan Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
Japan Molecular Diagnostics Test Volume By Major Application
Japan Major Infectious Disease Test Volume by Assay
Japan Major Infectious Disease Test Volume by Method
Japan Molecular Diagnostics Market By Major Application
Japan Molecular Diagnostics Market Estimated Sales And Market Shares of Major Suppliers
Japan Major Infectious Disease Diagnostics Market by Assay
Japan AIDS Testing Market Estimated Sales by Major Supplier
Japan Chlamydia Testing Market Estimated Sales by Major Supplier
Japan CMV Testing Market Estimated Sales by Major Supplier
Japan Gonorrhea Testing Market Estimated Sales by Major Supplier
Japan Hepatitis Testing Market Estimated Sales by Major Supplier
Japan Hepatitis C Testing Market Estimated Sales by Major Supplier
Japan Herpes Testing Market Estimated Sales by Major Supplier
Japan Meningitis Testing Market Estimated Sales by Major Supplier
Japan Mycoplasma Testing Market Estimated Sales by Major Supplier
Japan Pneumonia Testing Market Estimated Sales by Major Supplier
Japan Shigella Testing Market Estimated Sales by Major Supplier
Spain Molecular Diagnostics Test Volume And Sales By Major Application
Spain Laboratories Performing DNA Sequencing By Market Segment
Spain Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
Spain Molecular Diagnostics Test Volume By Major Application
Spain Major Infectious Disease Test Volume by Assay
Spain Major Infectious Disease Test Volume by Method
Spain Molecular Diagnostics Market By Major Application
Spain Molecular Diagnostics Market Estimated Sales And Market Shares of Major Suppliers
Spain Major Infectious Disease Diagnostics Market by Assay
Spain AIDS Testing Market Estimated Sales by Major Supplier
Spain Chlamydia Testing Market Estimated Sales by Major Supplier
Spain CMV Testing Market Estimated Sales by Major Supplier
Spain Gonorrhea Testing Market Estimated Sales by Major Supplier
Spain Hepatitis Testing Market Estimated Sales by Major Supplier
Spain Hepatitis C Testing Market Estimated Sales by Major Supplier
Spain HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
Spain Herpes Testing Market Estimated Sales by Major Supplier
Spain Influenza Testing Market Estimated Sales by Major Supplier
Spain Meningitis Testing Market Estimated Sales by Major Supplier
Spain Mycoplasma Testing Market Estimated Sales by Major Supplier
U.K. Molecular Diagnostics Test Volume And Sales By Major Application
U.K. Laboratories Performing DNA Sequencing By Market Segment
U.K. Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
U.K. Molecular Diagnostics Test Volume By Major Application
U.K. Major Infectious Disease Test Volume by Assay
U.K. Major Infectious Disease Test Volume by Method
U.K. Molecular Diagnostics Market By Major Application
U.K. Molecular Diagnostics Market Estimated Sales And Market Shares of Major Suppliers
U.K. Major Infectious Disease Diagnostics Market by Assay
U.K. AIDS Testing Market Estimated Sales by Major Supplier
U.K. Gonorrhea Testing Market Estimated Sales by Major Supplier
U.K. Hepatitis Testing Market Estimated Sales by Major Supplier
U.K. Hepatitis C Testing Market Estimated Sales by Major Supplier
U.K. HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
U.K. Influenza Testing Market Estimated Sales by Major Supplier
U.K. Mycoplasma Testing Market Estimated Sales by Major Supplier
U.K. Pneumonia Testing Market Estimated Sales by Major Supplier
U.K. Shigella Testing Market Estimated Sales by Major Supplier
U.S.A. Molecular Diagnostics Test Volume And Sales By Major Application
U.S.A. Laboratories Performing DNA Sequencing By Market Segment
U.S.A. Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
U.S.A. Molecular Diagnostics Test Volume by Major Application
U.S.A. Major Infectious Disease Test Volume by Assay
U.S.A. Major Infectious Disease Test Volume by Method
U.S.A. Molecular Diagnostics Market By Major Application
U.S.A. Molecular Diagnostics Market Estimated Sales And Market Shares of Major Suppliers
U.S.A. Major Infectious Disease Diagnostics Market by Assay
U.S.A. AIDS Testing Market Estimated Sales by Major Supplier
U.S.A. Adenovirus Testing Market Estimated Sales by Major Supplier
U.S.A. Chlamydia Testing Market Estimated Sales by Major Supplier
U.S.A. CMV Testing Market Estimated Sales by Major Supplier
U.S.A. Echovirus Testing Market Estimated Sales by Major Supplier
U.S.A. Enterovirus Testing Market Estimated Sales by Major Supplier
U.S.A. EBV Testing Market Estimated Sales by Major Supplier
U.S.A. Gonorrhea Testing Market Estimated Sales by Major Supplier
U.S.A. Hepatitis Testing Market Estimated Sales by Major Supplier
U.S.A. Hepatitis C Testing Market Estimated Sales by Major Supplier
U.S.A. HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
U.S.A. Herpes Testing Market Estimated Sales by Major Supplier
U.S.A. Influenza Testing Market Estimated Sales by Major Supplier
U.S.A. Meningitis Testing Market Estimated Sales by Major Supplier
U.S.A. Mycoplasma Testing Market Estimated Sales by Major Supplier
U.S.A. Pneumonia Testing Market Estimated Sales by Major Supplier
U.S.A. Rabies Testing Market Estimated Sales by Major Supplier
U.S.A. RSV Testing Market Estimated Sales by Major Supplier
U.S.A. Salmonella Testing Market Estimated Sales by Major Supplier
U.S.A. Shigella Testing Market Estimated Sales by Major Supplier
U.S.A. West Nile Virus Nat Market Reagent Sales by Major Supplier

---